CGP-57380 | m-entrepreneurship.com

Product Name :
CGP-57380

Search keywords :
CGP 57380

drugId :
null

Target Vo:
MAP kinase-interacting serine/threonine-protein kinase MNK1

Target Vo Short Name :
MKNK1

Moa_Name:
MAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Risankizumab Purity & Documentation
HDAC4 Rabbit mAb Biological Activity
IL17A Antibody: IL17A Antibody is an unconjugated, approximately 15 kDa, rabbit-derived, anti-IL17A polyclonal antibody. IL17A Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in mouse, rat, background without labeling.

Author: Betaine hydrochloride

Related Posts